Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P43026 (
lipopolysaccharide
)
62,215
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Monoclonal non-specific suppressor factor (MNSF), a lymphokine produced by a murine T-cell hybridoma, possesses pleiotrophic non-specific suppressive functions.
MNSFbeta
(a subunit of MNSF) is a 14.5 kDa fusion protein consisting of a protein with 36% homology with ubiquitin and ribosomal protein S30. The ubiquitin-like segment of
MNSFbeta
(Ubi-L) is an 8 kDa polypeptide with MNSF-like activity. Since the amino acids critical for the ubiquitination process are conserved in Ubi-L, we examined whether Ubi-L may conjugate with intracellular proteins in a manner similar to the ubiquitin system. Rabbit polyclonal antibodies specific for Ubi-L detected the induction of Ubi-L conjugations, including 33.5 kDa and 70 kDa molecules in concanavalin A (Con A)-stimulated T-cells, but not in
lipopolysaccharide
-stimulated B-cells and macrophages. High-molecular-mass conjugates were consistently present in pan-T-cells. However, free Ubi-L could not be observed in all the cells tested. Con A-activated CD8+ T-cells, but not CD4+ T-cells, induced the 70 kDa Ubi-L adduct, which was recognized by an anti-MNSF monoclonal antibody. Treatment of CD8+ T-cells with interferon (IFN) gamma also caused the expression of the 70 kDa Ubi-L adduct, whereas the responses to IFNalpha and IFNbeta were nil. Antigen- and Con A- stimulated D.10 G4.1, a murine T helper clone type 2, induced the 33.5 kDa, but not the 70 kDa, adduct. These results suggest a role for Ubi-L conjugation in the regulation of T-cell activation.
...
PMID:Ubiquitin-like polypeptide conjugates to acceptor proteins in concanavalin A- and interferon gamma-stimulated T-cells. 948 Aug 75
MNSFbeta
is a ubiquitously expressed member of the ubiquitin-like family that has been implicated in various biological functions. Previous studies have demonstrated that
MNSFbeta
covalently binds to intracellular proapoptotic protein Bcl-G in mitogen-activated murine T cells. In this study, we further investigated the intracellular mechanism of action of
MNSFbeta
in macrophage cell line, Raw 264.7 cells. We present evidence that
MNSFbeta
.Bcl-G complex associates with ERKs in non-stimulated Raw 264.7. We found that
MNSFbeta
.Bcl-G directly bound to ERKs and inhibited ERK activation by MEK1. In Raw 264.7 cells treated with
MNSFbeta
small interfering RNA (siRNA)
lipopolysaccharide
(
LPS
)-induced ERK1/2 activation was enhanced and
LPS
-induced JNK and p38 activation was unaffected. SiRNA-mediated knockdown of
MNSFbeta
increased tumor necrosis factor alpha (TNFalpha) expression at mRNA and protein levels in
LPS
-stimulated Raw 264.7 cells. Finally, we found that transfection with
MNSFbeta
expression construct resulted in a significant inhibition of
LPS
-induced ERK activation and TNFalpha production. Co-transfection experiments with
MNSFbeta
and Bcl-G greatly enhanced this inhibition. Collectively, these findings indicate that
MNSFbeta
might be implicated in the macrophage response to
LPS
.
...
PMID:The ubiquitin-like protein MNSFbeta regulates ERK-MAPK cascade. 1662 90